Back to CA Clearstead Advisors, LLC

MRNAMRNA

Showing 8 of 26 quarters

Position history for CAClearstead Advisors, LLC's holdings in Moderna, Inc.

Yes. Clearstead Advisors holds 2,351 shares of MRNA (Moderna), worth $452,870, as of its Q3 2026 13F filing. It increased the position by 1,445 shares (+159.5%) from Q2 2026. Clearstead Advisors has held MRNA since Q2 2020, across 26 quarterly 13F filings.

Current Value

$452,870

Current Shares

2,351

Total Value Change

+$448,213

Total Shares Change

+2,239

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
2,351
+159.5%
$452,8700.0%$192.57
39
2026-Q2
Increased
906
+731.2%
$63,4480.0%$70.03
34
2026-Q1
Decreased
109
-22.7%
$5,5380.0%$50.80
0
2025-Q4
Increased
141
+8.5%
$4,1590.0%$29.49
16
2025-Q3
Increased
130
+19.3%
$3,3580.0%$25.83
11
2025-Q2
Decreased
109
-9.2%
$3,0080.0%$27.59
0
2025-Q1
Increased
120
+7.1%
$3,4020.0%$28.35
15
2024-Q4
Increased
112
+4.7%
$4,6570.0%$41.58
16

Optional analytics helps us improve. How it’s used